Japan, Nov. 11 -- 株式会社高儀 holds the trademark for '*ＴＡＫＡＧＩ.' Other related details are as follows: Application Number: Reg.No.6980769 Class: 06 Status: LIVE-REGISTRATION-Published for Opposition Filing Date: March 24 Registration Date: Oct. 27 The original document can be viewed at: https://www.j-platpat.inpit.go.jp/c1801/TR/JP-2025-030741/40/en Disclaimer: Curated by HT Syndication....
Japan, Nov. 11 -- 株式会社高儀 holds the trademark for '*ＴＡＫＡＧＩ.' Other related details are as follows: Application Number: Reg.No.6980770 Class: 09 Status: LIVE-REGISTRATION-Published for Opposition Filing Date: March 24 Registration Date: Oct. 27 The original document can be viewed at: https://www.j-platpat.inpit.go.jp/c1801/TR/JP-2025-030742/40/en Disclaimer: Curated by HT Syndication....
Japan, Nov. 11 -- 株式会社高儀 holds the trademark for '*ＴＡＫＡＧＩ.' Other related details are as follows: Application Number: Reg.No.6980771 Class: 12 Status: LIVE-REGISTRATION-Published for Opposition Filing Date: March 24 Registration Date: Oct. 27 The original document can be viewed at: https://www.j-platpat.inpit.go.jp/c1801/TR/JP-2025-030743/40/en Disclaimer: Curated by HT Syndication....
Japan, Nov. 11 -- 株式会社グリーンライフ holds the trademark for 'ＧＲＥＥＮ　ＬＩＦＥ.' Other related details are as follows: Application Number: Reg.No.6980772 Class: 07,11 Status: LIVE-REGISTRATION-Published for Opposition Filing Date: March 24 Registration Date: Oct. 27 The original document can be viewed at: https://www.j-platpat.inpit.go.jp/c1801/TR/JP-2025-03...
Japan, Nov. 11 -- 西岡　慎也 holds the trademark for 'パープルオーシャン.' Other related details are as follows: Application Number: Reg.No.6980773 Class: 35 Status: LIVE-REGISTRATION-Published for Opposition Filing Date: March 24 Registration Date: Oct. 27 The original document can be viewed at: https://www.j-platpat.inpit.go.jp/c1801/TR/JP-2025-030815/40/en Disclaimer: Curated by HT Syndication....
Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059590) titled 'Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals' on Nov. 11. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - Graduate School of Me...
Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059724) titled 'The exploratory study on the effect of peptide-containing foods in healthy adults: A randomized, double-blind, parallel-group controlled trial' on Nov. 11. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Faculty of Agriculture,Kyu...
Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059716) titled 'A Phase III Clinical Study of CHO in Subjects with Ocular Discomfort' on Nov. 11. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - ROHTO pharmaceutical CO.,LTD Condition: Condition - Subjects who have subjective symptoms of ocular dry...
Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059257) titled 'Ward-Based Comparison of Nurses' Attitudes Toward Palliative Care Using the Frommelt Attitudes Toward Care of the Dying (FATCOD) Scale' on Nov. 11. Study Type: Observational Primary Sponsor: Institute - Kawasaki Medical School Condition: Condition - none Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - This study aimed ...
Tokyo, Nov. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059719) titled 'Effects of Test Beverage Consumption on Health Benefits' on Nov. 11. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Mizkan Holdings Co., Ltd. Condition: Condition - Healthy person Classification by malignancy - Others Genomic in...